Ces Urol 2005, 9(3):31-35 | DOI: 10.48095/cccu2005019

Effect of age, gender and ecog score on prognosis of renal carcinoma

I. Kawaciuk, L. Hyršl, P. Dušek, L. Jarolím, M. Schmidt, V. Kaliská, M. Chocholatý, M. Urbanová
Urologická klinika 2. LF UK a FN Motol, Praha

In the group of 316 patients operated for renal cell carcinoma were 191 men and 125 women (1,5 : 1). The five-year survival of men and women was 59,7% and 67,2%, respectively. The difference was not significant (p = 0,18). Distant metastasis had 14,1% men and 12% women. There were 6,3% inoperable tumors in men and only 1,6% in women. Frequency of incidental carcinomas was insignificantly higher (p = 0,24) in women (31,2 vs 25,1%). Comparison concerning TNM-classification 2002 showed higher incidence of tumors in stage I in women (36,8 vs 23%), on the contrary in men in stage IV (20,4 vs 16,8%). The difference was at the borderline of significance (p = 0,05). The average age of patients in the whole group (n = 316) was 61,5 years; 60,9 in men, 62,3 in women. The five-year survival has been decreasing more significantly from the 8th decennium. This feature is probably in coincidence with life expectancy in normal population with similar age and gender distribution.
Patients with ECOG score 0, 1 and 2 had five-year survival 76,4%, 60,2% and 40%, respectively. None of the patients with ECOG score 3 survived five years. ECOG score at the time of surgery had higher impact on survival rate in patients in stage I and II, on the contrary ECOG score had no impact on survival rate in patients in stage III and IV.

Keywords: renal cell carcinoma, prognosis, gender, age, ECOG score

Published: June 1, 2005 


References

  1. Barsel VA, Chaimčajev JS. Matematičeskij analiz využivajemosti bolnych adenokarcinomoj počki. Urol Nefrol (Mosk.) 1975; 3: 44-48.
  2. Rafla S. Renal cell carcinoma. Natural history and results of treatment. Cancer 1970; 25: 26-40. Go to original source... Go to PubMed...
  3. Thompson IM, Shannon H, Ross G et al. An analysis of factors affecting survival in 150 patients with renal carcinoma. J Urol 1975; 114: 694-696. Go to original source... Go to PubMed...
  4. Giuliani L, Martorana G, Giberti C et al. Results of radical nephrectomy with extensive lymphadenectomy for renal cell carcinoma. J Urol 1983; 130: 664-668. Go to original source... Go to PubMed...
  5. Kirkali Z, Tuzel E, Mungan MU. Recent advances in kidney cancer and metastatic disease. BJU Int 2001; 88: 818-824. Go to original source... Go to PubMed...
  6. McNichols DW, Segura JW, De Weerd JH. Renal cell carcinoma: long-term survival and late recurrence. J Urol 1981; 126: 17-23. Go to original source... Go to PubMed...
  7. Lieber MM, Tomera FM, Taylor WF et al. Renal adenocarcinoma in young adults: survival and variables affecting prognosis. J Urol 1981; 125: 164-168. Go to original source... Go to PubMed...
  8. Mostofi FK, Davis CJ. Pathology of tumors of the kidney. In: Javadpour N (ed). Cancer of the kidney. New York: Thieme Stratton 1984: 15-32.
  9. Fukuda M, Satomi Y, Asakura T et al. Prognosis in the cases with renal cell carcinoma according to clinical parameters. Nippon Hinyokika Gakkai Zasshi 1998; 89: 647-656. Go to original source... Go to PubMed...
  10. Onodera Y, Matsuda N, Ohta M et al. Prognostic significance of tumor grade for renal cell carcinoma. Int J Urol 2000; 7: 4-9. Go to original source... Go to PubMed...
  11. Nomoto T, Nakagawa S, Sugimoto K et al. Prognostic factors in a patients with renal cell carcinoma. Nippon Hinyokika Gakkai Zasshi 1999; 90: 602-607. Go to original source... Go to PubMed...
  12. Onishi T, Ohishi Y, Goto H et al. Gender as a prognostic factor in patients with renal cell carcinoma. BJU Int 2002; 90: 32-36. Go to original source... Go to PubMed...
  13. Böttiger LE. Prognosis in renal carcinoma. Cancer 1970; 26: 780-787. Go to original source... Go to PubMed...
  14. Boxer RJ, Waisman J, Lieber MM et al. Renal cell carcinoma: computer analysis of 96 patients treated by nephrectomy. J Urol 1979; 122: 598-601. Go to original source... Go to PubMed...
  15. Rodriguez A, Patard JJ, Lobel B. Renal cell carcinoma in young adults: incidence, disease outcome and review of the literature. Arch Esp Urol 2002; 55: 969-975.
  16. Kofler K, Reichl E, Zischka-Konarsa W. Die Prognose des Nierenzell-Karcinoms: pathologisch-anatomische und klinische Gesichtspunkte. Virchows Arch (Pathol Anat) 1975; 368: 347-359. Go to original source... Go to PubMed...
  17. Wang Y, Huang C, Wu Y et al. Multivariate analysis of prognostic factors in renal cell carcinoma. Zhonghua Wai Ke Za Zhi 2000; 38: 442-444.
  18. Yusim I, Mermershtain W, Neulander E et al. Influence of age on the prognosis of patients with renal cell carcinoma (RCC). Onkologie 2002; 25: 548-550. Go to original source... Go to PubMed...
  19. Griffiths DF, Verdhese A, Golasch A et al. Contribution of grade, vascular invasion and age to outcome in clinically localized renal cell carcinoma. BJU Int 2002; 90: 26-31. Go to original source... Go to PubMed...
  20. Citterio G, Bertuzzi A, Tresoldi M et al. Prognostic factors for survival in metastatic renal cell carcinoma: retrospective analysis from 109 consecutive patients. Eur Urol 1997; 31: 286-291. Go to original source... Go to PubMed...
  21. Motzer RJ, Mazumdar M, Bacik J et al. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 1999; 17: 2530-2540. Go to original source... Go to PubMed...
  22. Mani S, Todd MB, Katz K et al. Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiers. J Urol 1995; 154: 35-40. Go to original source... Go to PubMed...
  23. Fallick ML, McDermott DF, Larock D et al. Nephrectomy before interleukin-2 therapy for patients with metastatic renal cell carcinoma. J Urol 1997; 158: 1691-1695. Go to original source... Go to PubMed...
  24. Wang Y, Huang C, Wu Y et al. Multivariate analysis of prognostic factors in renal cell carcinoma. Zhonghua Wai Ke Za Zhi 2000; 38: 442-444.
  25. Zisman A, Pantuck AJ, Dorey F et al. Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol 2001; 19: 1649-1657. Go to original source... Go to PubMed...
  26. Elson PJ, Witte RS, Trump DL. Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma. Cancer Res 1988; 48: 7310-7313.





Web časopisu Česká urologie je určen pouze pro lékaře a odborníky
z oblasti medicíny nebo farmacie.



Beru na vědomí, že informace zveřejněné na těchto stránkách
nejsou určeny pro laickou veřejnost.



Odejít Vstoupit